Target areas are identified through a combination of laboratory research and clinical trials. Scientists use techniques such as genomic sequencing to uncover the genetic mutations and pathways involved in cancer. Clinical trials then test therapies that target these areas to ensure their safety and efficacy. This process is iterative, with new discoveries and treatments constantly emerging from ongoing research.
